The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
In silico studies on the comparative characterization of the interactions of SARS‐CoV‐2 spike glycoprotein with ACE‐2 receptor homologs and human TLRs
Open accessAbstract
Coronavirus disease‐2019 (COVID‐19) outbreak due to novel coronavirus or severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection has come out as a major threat for mankind in recent times. It is continually taking an enormous toll on mankind by means of increasing number of deaths, associated comorbidities, and socioeconomic loss around the globe. Unavailability of chemotherapeutics/vaccine has posed tremendous challenges to scientists and doctors for developing an urgent therapeutic strategy. In this connection, the present in silico study aims to understand the sequence divergence of spike protein (the major infective protein of SARS‐CoV‐2), its mode of interaction with the angiotensin‐converting enzyme‐2 receptor (ACE2) receptor of human and related animal hosts/reservoir. Moreover, the involvement of the human Toll‐like receptors (TLRs) against the spike protein has also been demonstrated. Our data indicated that the spike glycoprotein of SARS‐CoV‐2 is phylogenetically close to bat coronavirus and strongly binds with ACE2 receptor protein from both human and bat origin. We have also found that cell surface TLRs, especially TLR4 is most likely to be involved in recognizing molecular patterns from SARS‐CoV‐2 to induce inflammatory responses. The present study supported the zoonotic origin of SARS‐CoV‐2 from a bat and also revealed that TLR4 may have a crucial role in the virus‐induced inflammatory consequences associated with COVID‐19. Therefore, selective targeting of TLR4‐spike protein interaction by designing competitive TLR4‐antagonists could pave a new way to treat COVID‐19. Finally, this study is expected to improve our understanding on the immunobiology of SARS‐CoV‐2 and could be useful in adopting spike protein, ACE2, or TLR‐guided intervention strategy against COVID‐19 shortly.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gautret, P., Lagier, J.-C., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V. E., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105949 · Cited by 5,288
RetractedA novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Chan, J. F.-W., Yuan, S., Kok, K.-H., To, K. K.-W., Chu, H., Yang, J., Xing, F., Liu, J., Yip, C. C.-Y., Poon, R. W.-S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,944
A novel coronavirus outbreak of global health concern
Wang, C., Horby, P. W., Hayden, F. G., & Gao, G. F. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30185-9 · Cited by 7,700
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., Zhang, Q., Shi, X., Wang, Q., Zhang, L., et al. (2020) · Nature · doi:10.1038/s41586-020-2180-5 · Cited by 5,983
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
Rothan, H. A., & Byrareddy, S. N. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102433 · Cited by 5,840
The proximal origin of SARS-CoV-2
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0820-9 · Cited by 5,081
Hui, D. S., I Azhar, E., Madani, T. A., Ntoumi, F., Kock, R., Dar, O., Ippolito, G., Mchugh, T. D., Memish, Z. A., Drosten, C., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.01.009 · Cited by 3,809
Compassionate Use of Remdesivir for Patients with Severe Covid-19
Grein, J., Ohmagari, N., Shin, D., Diaz, G., Asperges, E., Castagna, A., Feldt, T., Green, G., Green, M. L., Lescure, F.-X., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007016 · Cited by 2,737
Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak
Zhang, T., Wu, Q., & Zhang, Z. (2020) · Current Biology · doi:10.1016/j.cub.2020.03.022 · Cited by 1,397
Genotype and phenotype of COVID-19: Their roles in pathogenesis
Mousavizadeh, L., & Ghasemi, S. (2021) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2020.03.022 · Cited by 962
Fu, Y., Cheng, Y., & Wu, Y. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00207-4 · Cited by 788
Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak
Zhang, T., Wu, Q., & Zhang, Z. (2020) · Current Biology · doi:10.1016/j.cub.2020.03.063 · Cited by 426
TLR2 and TLR4 mediated host immune responses in major infectious diseases: a review
Mukherjee, S., Karmakar, S., & Babu, S. P. S. (2016) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2015.10.011 · Cited by 410
Self-citationBhattacharya, M., Sharma, A. R., Patra, P., Ghosh, P., Sharma, G., Patra, B. C., Lee, S., & Chakraborty, C. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25736 · Cited by 389
COVID‐2019: The role of the nsp2 and nsp3 in its pathogenesis
Angeletti, S., Benvenuto, D., Bianchi, M., Giovanetti, M., Pascarella, S., & Ciccozzi, M. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25719 · Cited by 386
Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses
Raoult, D., Zumla, A., Locatelli, F., Ippolito, G., & Kroemer, G. (2020) · Cell Stress · doi:10.15698/cst2020.04.216 · Cited by 386
Chakraborty, C., Sharma, A. R., Sharma, G., Bhattacharya, M., & Lee, S. S. (2020) · PubMed · doi:10.26355/eurrev_202004_20871 · Cited by 252
Toll‐like receptor polymorphism in host immune response to infectious diseases: A review
Mukherjee, S., Huda, S., & Sinha Babu, S. P. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12771 · Cited by 250
Self-citationThe 2019 novel coronavirus disease (COVID-19) pandemic: A zoonotic prospective
Chakraborty, C., Lee, S., Sharma, A., Bhattacharya, M., & Sharma, G. (2020) · Asian Pacific Journal of Tropical Medicine · doi:10.4103/1995-7645.281613 · Cited by 99
Mukherjee, S., Mukherjee, N., Saini, P., Gayen, P., Roy, P., & Babu, S. P. S. (2014) · Infectious Diseases of Poverty · doi:10.1186/2049-9957-3-13 · Cited by 25
Self-citation
Cited by
Innate immunity: the first line of defense against SARS-CoV-2
Diamond, M. S., & Kanneganti, T.-D. (2022) · Nature Immunology · doi:10.1038/s41590-021-01091-0 · Cited by 618
Role of Toll‐like receptors in the pathogenesis of COVID‐19
Khanmohammadi, S., & Rezaei, N. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26826 · Cited by 370
Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines
Fara, A., Mitrev, Z., Rosalia, R. A., & Assas, B. M. (2020) · Open Biology · doi:10.1098/rsob.200160 · Cited by 369
SARS-CoV-2 spike protein interacts with and activates TLR41
Zhao, Y., Kuang, M., Li, J., Zhu, L., Jia, Z., Guo, X., Hu, Y., Kong, J., Yin, H., Wang, X., et al. (2021) · Cell Research · doi:10.1038/s41422-021-00495-9 · Cited by 354
Aboudounya, M. M., & Heads, R. J. (2021) · Mediators of Inflammation · doi:10.1155/2021/8874339 · Cited by 346
Metadata
- Authors
- Choudhury, A., & Mukherjee, S.
- Venue
- Journal of Medical Virology
- Publisher
- Wiley
- Published
- 2020-05-17
- Volume
- 92
- Issue
- 10
- Pages
- 2105-2113
- ISSN
- 0146-6615 (ISSN-L)
- 1096-9071
- OpenAlex
- W3021577931
- Cited by
- 488
- References
- 22
- FWCI
- 10.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.